Supplementary Data 3 from Discovery of JNJ-63576253, a Next-Generation Androgen Receptor Antagonist Active Against Wild-Type and Clinically Relevant Ligand Binding Domain Mutations in Metastatic Castration-Resistant Prostate Cancer

التفاصيل البيبلوغرافية
العنوان: Supplementary Data 3 from Discovery of JNJ-63576253, a Next-Generation Androgen Receptor Antagonist Active Against Wild-Type and Clinically Relevant Ligand Binding Domain Mutations in Metastatic Castration-Resistant Prostate Cancer
المؤلفون: Gilles Bignan, Marco M. Gottardis, Yolanda T. Chong, Christopher J. Parrett, Kathryn Packman, Lieven Meerpoel, Geert Van Hecke, Georges Habineza, James R. Bischoff, Steffen Jaensch, Janine Ondrus, Ian Hickson, Zhuming Zhang, Peter J. Connolly, Vineet Pande, Tammy L. Bush, Jonathan R. Branch
بيانات النشر: American Association for Cancer Research (AACR), 2023.
سنة النشر: 2023
الوصف: The synthetic androgen R1881 induces maximum proliferation in LNCaP AR/cs and LNCaP F877L cell lines at 0.1nM concentrations
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9357ac4b74d0a19b1138db2c193e9a97
https://doi.org/10.1158/1535-7163.22522977.v1
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....9357ac4b74d0a19b1138db2c193e9a97
قاعدة البيانات: OpenAIRE